Lymph Node Evaluation after Neoadjuvant Chemotherapy for Patients with Gastric Cancer

被引:11
|
作者
Shannon, Adrienne B. [1 ]
Straker, Richard J., III [1 ]
Keele, Luke [1 ]
Fraker, Douglas L. [2 ]
Roses, Robert E. [2 ]
Miura, John T. [2 ]
Karakousis, Giorgos C. [2 ]
机构
[1] Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Dept Surg, Div Endocrine & Oncol Surg, 3400 Spruce St, Philadelphia, PA 19104 USA
关键词
SURVIVAL; METAANALYSIS; OUTCOMES; SURGERY; IMPACT;
D O I
10.1245/s10434-021-10803-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Adequate lymphadenectomy with at least 16 nodes retrieved at the time of gastrectomy is a quality measure recommended to ensure adequate staging. The minimum nodal retrieval recommended after receipt of neoadjuvant chemotherapy (NACT) is less defined. Methods Patients with clinical stages 1 to 3 gastric adenocarcinoma who received NACT and surgical resection were identified from the 2004-2015 National Cancer Database. The optimal nodal harvest number was calculated with Cox spline regression modeling. Cohorts with a nodal harvest higher or lower than this number were 1:1 propensity score-matched. Overall survival (OS) was analyzed using Kaplan-Meier survival estimates. Results Among 4337 patients receiving NACT, the optimal minimal nodal harvest at gastrectomy was 23 nodes. Compared with the patients who had fewer than 23 nodes retrieved, the patients with at least 23 nodes examined (n = 1073, 24.7%) were more likely to be female (26.1% vs 22%; p = 0.006) and non-white (29.3% vs 18.5%; p < 0.0001), to have a Charlson-Deyo score of 0 (71.5% vs 66.8%; p = 0.005), and to have undergone resection at an academic facility (67.9% vs 51.5%; p < 0.0001). The patients with at least 23 nodes examined had higher proportions of high-grade tumor (62% vs 57.4%; p = 0.030), pT3 or pT4 tumor (56.3% vs 48.7%; p < 0.0001), body tumor (21.3% vs 12.5%; p < 0.0001), or antrum/pylorus tumor (15.3% vs 11.4%; p < 0.0001). The patients with at least 23 nodes were more likely to have lymph node metastases identified (61% vs 51%; p < 0.0001). After matching, the patients with at least 23 nodes (n = 990) demonstrated an improved 5-year OS (57.9% vs 49%; p = 0.001). Conclusions The extent of lymphadenectomy during gastrectomy for gastric adenocarcinoma should not be reduced after NACT because adequate lymph node retrieval remains important for prognostication.
引用
收藏
页码:1242 / 1253
页数:12
相关论文
共 50 条
  • [21] Validity of sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
    Jinno, H.
    Asaga, S.
    Sakata, M.
    Kubota, T.
    Kitajima, M.
    Mukai, M.
    Kubo, A.
    Ikeda, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Sentinel lymph node biopsy in patients with clinically negative lymph node after neoadjuvant chemotherapy
    Park, Sung-Jin
    Lee, Woo-Yong
    Yang, Geun-Ho
    Park, Kyeongmee
    Han, Sehwan
    [J]. JOURNAL OF BREAST CANCER, 2007, 10 (04) : 254 - 257
  • [23] Prophylactic para-aortic lymph node dissection after neoadjuvant chemotherapy for gastric cancer with bulky lymph node metastasis.
    Kenichiro, Furukawa
    Matsumoto, Yosuke
    Soneda, Wataru
    Koseki, Yusuke
    Fujiya, Keiichi
    Tanizawa, Yutaka
    Bando, Etsuro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 344 - 344
  • [24] Lymph node response to neoadjuvant chemotherapy as an independent prognostic factor in gastric cancer
    Wada, Yuma
    Nishi, Masaaki
    Yoshikawa, Kozo
    Takasu, Chie
    Tokunaga, Takuya
    Nakao, Toshihiro
    Kashihara, Hideya
    Yoshimoto, Toshiaki
    Shimada, Mitsuo
    [J]. ONCOLOGY LETTERS, 2022, 24 (05)
  • [25] Prognostic Factors for Para-aortic Lymph Node Dissection After Neoadjuvant Chemotherapy for Gastric Cancer
    Endo, Shunji
    Ikenaga, Masakazu
    Yamada, Terumasa
    Tamura, Shigeyuki
    Sasaki, Yo
    [J]. ANTICANCER RESEARCH, 2020, 40 (04) : 2351 - 2357
  • [26] Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer
    Julian, TB
    Patel, N
    Dusi, D
    Olson, P
    Nathan, G
    Jasnosz, K
    Isaacs, G
    Wolmark, N
    [J]. AMERICAN JOURNAL OF SURGERY, 2001, 182 (04): : 407 - 410
  • [27] Sentinel Lymph NOde Biopsy after Neoadjuvant Chemotherapy in Breast Cancer
    Cepedello Boiso, I.
    Urena Lara, M.
    Duenas Rodriguez, B.
    Ramirez Tortosa, C.
    Martinez Ferrol, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S419 - S420
  • [28] Sentinel Lymph Node Biopsy is a Reliable Method for Lymph Node Evaluation in Neoadjuvant Chemotherapy-treated Patients with Breast Cancer
    Koslow, Starr B.
    Eisenberg, Rachel E. K.
    Qiu, Queenie
    Chen, Zhengming
    Swistel, Alexander
    Shin, Sandra J.
    [J]. AMERICAN SURGEON, 2014, 80 (02) : 171 - 177
  • [29] Sentinel Lymph Node Biopsy Is a Reliable Method for Lymph Node Evaluation in Neoadjuvant Chemotherapy Treated Breast Cancer Patients.
    Kaplan, R.
    Qiu, Q.
    Monni, S.
    Swistel, A.
    Shin, S.
    [J]. CANCER RESEARCH, 2011, 71
  • [30] The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma
    Zhu, Kankai
    Jin, Hailong
    Li, Zhijian
    Gao, Yuan
    Zhang, Qing
    Liu, Xiaosun
    Yu, Jiren
    [J]. JOURNAL OF GASTRIC CANCER, 2021, 21 (01) : 49 - 62